profit from every $100 of sales.
$0$100
Trupanion
$34.48+0.52% today
-12.5% in 1 year
1-year low $21.461-year high $39.39
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $76.76 for every $1 of profit it makes in a year.
CheapExpensive
Not measured for banks and insurers: deposits and policy reserves count as debt, so the usual debt test says nothing about them.
Money in, money out
What Trupanion sold, what it kept, and what it did with the cash.
Sales went from $905 million in 2022 to $1.44 billion in 2025, with $19.4 million of profit last year.
SalesProfit
Trupanion handed back 5% of the cash it generated last year.
Buybacks $4M
Free cash flow 2025$75M
Bought back its own shares$4M
Paid as dividends–
Cash vs. debt$138M vs. $112M
Trupanion vs. similar companies
Trupanion grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Trupanion | 76.8× · Very expensive | ||
 Assurant | 18.1× · Fair price | ||
 Fidelity National Financial | 19.3× · Fair price | ||
 Beazley | 8.6× · Cheap | ||
 Medibank Private | 29.7× · Fair price |
AI analysis
An AI analyst reads Trupanion's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 905 | 1,109 | 1,286 | 1,439 | |
| 122 | 131 | 179 | 231 | |
| 47 | 37 | 67 | 101 | |
| -29 | -20 | 21 | 52 | |
| -45 | -45 | -10 | 19 | |
| -1.10 | -1.08 | -0.23 | 0.45 | |
| 13.5% | 11.8% | 13.9% | 16.1% | |
| 5.2% | 3.3% | 5.2% | 7.0% | |
| -4.9% | -4.0% | -0.7% | 1.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 672 | 783 | 807 | 915 |
| Cash | 66 | 148 | 160 | 138 |
| Total debt | 69 | 129 | 129 | 112 |
| Total liabilities | 366 | 479 | 484 | 531 |
| 305 | 304 | 323 | 384 | |
| 41 | 41 | 42 | 44 | |
| -8.4% | -6.0% | 0.8% | 5.7% | |
| -14.6% | -14.7% | -3.0% | 5.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -8 | 19 | 48 | 89 | |
| 17 | 18 | 10 | 14 | |
| -25 | 0 | 39 | 75 | |
| Dividends paid | – | – | – | – |
| 10 | 2 | 3 | 4 | |
| 33 | 33 | 33 | 38 |
This is a bank or insurer, so cash-flow and debt ratios are left out: borrowing and lending is the business itself. Price to book and return on equity are the measures that matter here.
Valuation
- 76.8×
- 64.0×
- –
- 2.4×
- 1.0×
- 1.3%
- 0.0%
Profitability
- 1.4%
- 3.4%
- -6.2%
- 6.9%
- 2.8%
Growth
- +16.7%
- –
- –
- +1.7%
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 46%of 852
Bottom 22%of 733
Bottom 4%of 863
Top 28%of 860
Bottom 44%of 920
What analysts expect
- Average price target
- $38.00
- Range
- $34.00 – $45.00
- 3 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 0.11 | 0.07 | +57.1% |
| Feb 12, 2026 | 0.13 | 0.14 | −7.1% |
| Nov 6, 2025 | 0.13 | 0.89 | −85.4% |
| Aug 7, 2025 | 0.22 | -0.03 | +833.3% |
| May 1, 2025 | -0.03 | -0.04 | +25.0% |
| Feb 19, 2025 | 0.04 | 0.06 | −33.3% |
| Oct 30, 2024 | 0.03 | -0.06 | +150.0% |
| Aug 8, 2024 | -0.14 | -0.18 | +22.2% |
News
Trupanion expects $179M-$182M of adjusted operating income in 2026 while advancing a new digital product launch next summerSeeking Alpha · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
34No pass
Benjamin Graham
27No pass
Philip Fisher
30No pass
Peter Lynch
62Pass
Joel Greenblatt
2No pass
Charlie Munger
23No pass
Terry Smith
27No pass
Questions about Trupanion
Is Trupanion a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Trupanion AI analysis
What does Trupanion do?
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It is in Insurance - Specialty.
Does Trupanion pay a dividend?
No. Trupanion does not pay a dividend at the moment; in 2025 it returned $3.71 million to shareholders by buying back its own shares.
Is Trupanion stock halal?
No. Trupanion does not pass our halal screen: its main business, conventional insurance, is not permitted. How we check
How has Trupanion stock done over the past year?
Down 12.5% over the past twelve months, to $34.48. It traded between $21.46 and $39.39 and is 12.5% below its high.
Who are Trupanion's competitors?
The largest listed companies in the same industry are Assurant, Fidelity National Financial, Beazley and Medibank Private. The peers table on this page compares their profit, growth and price with Trupanion's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.